サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：乳房生検の世界市場：2022-2028年
市場調査レポート
商品コード
1123234

乳房生検の世界市場：2022-2028年

Global Breast Biopsy Market Research and Forecast 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 125 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
乳房生検の世界市場：2022-2028年
出版日: 2022年07月30日
発行: Orion Market Research
ページ情報: 英文 125 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乳房生検の市場規模は予測期間中に8.2%のCAGRで大きく成長すると予測されています。

乳癌罹患率の高さ、乳癌検診プログラムの増加、低侵襲性乳房生検の採用率の上昇、乳癌研究への高い支出などの要因が同市場の成長を推進しています。さらに、吸引式生検のような新技術の導入、有望な臨床試験、女性の意識向上も市場に機会を示しています。

当レポートでは、世界の乳房生検の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 市場概要・洞察

第3章 競合情勢

  • 主要企業分析
  • 主要戦略分析

第4章 市場決定要因

  • 推進要因
  • 抑制要因
  • 機会

第5章 市場分析：区分別

  • 世界の乳房生検市場：タイプ別
    • 細針生検
    • 針生検
    • 外科生検
    • その他（リンパ節および吸引生検）
  • 世界の乳房生検市場：製品別
    • 生検針
    • ガイダンスシステム
    • 生検台
    • ローカリゼーションワイヤー
    • アッセイキット
    • その他
  • 世界の乳房生検市場：ガイド技術別
    • MRIガイド下生検
    • 超音波ガイド下生検
    • マンモグラフィガイド下定位生検
    • CTガイド下生検
    • 他の
  • 世界の乳房生検市場：エンドユーザー別
    • 病院
    • 診断センター
    • 研究機関

第6章 地域分析

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 企業プロファイル

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Co.
  • Benetec Medical Systems
  • Merit Medical Systems
  • Cigna International Corp.
  • Cook Group Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • IMS GIOTTO S.P.A.
  • Leica Biosystems Nussloch GmbH（Devicor Medical Products, Inc.）
  • Medtronic plc
  • NORAS MRI Products GmbH
  • Oncocyte Corp.
  • Planmeca Group
  • QIAGEN GmbH
  • Scion Medical Technologies, LLC.
  • Trivitron Healthcare
  • United Medical Systems Inc.
  • VigeoSRL
図表

LIST OF TABLES

  • 1. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 2. GLOBAL FINE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL CORE NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL SURGICAL BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL OTHERS TYPE BIOPYS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 7. GLOBAL BIOPSY NEEDLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL BIOPSY TABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL ASSAY KIT FOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL GUIDANCE SYSTEMS FOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL LOCALIZATION WIRES FOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL OTHER FOR BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 14. GLOBAL MRI-GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL ULTRASOUND GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL CT-GUIDED BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 20. GLOBAL BREAST BIOPSY IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. GLOBAL BREAST BIOPSY IN DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 22. GLOBAL BREAST BIOPSY IN RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 24. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 25. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT,2020-2027 ($ MILLION)
  • 26. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 27. NORTH AMERICAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 28. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 29. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 30. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 31. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 32. EUROPEAN BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 34. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 35. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 36. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 37. ASIA-PACIFIC BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 39. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 40. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 41. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY GUIDED TECHNOLOGY, 2020-2027 ($ MILLION)
  • 42. REST OF THE WORLD BREAST BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BREAST BIOPSY MARKET SHARE BY TYPE,2020 VS 2027 (%)
  • 2. GLOBAL BREAST BIOPSY MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 3. GLOBAL BREAST BIOPSY MARKET SHARE BY GUIDED TECHNOLOGY, 2020 VS 2027 (%)
  • 4. GLOBAL BREAST BIOPSY MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 5. GLOBAL BREAST BIOPSY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL FINE NEEDLE BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL CORE NEEDLE BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL SURGICAL BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL OTHERS BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL BIOPSY NEEDLES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL BIOPSY TABLES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL ASSAY KIT MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL MRI-GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL GUIDANCE SYSTEMS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBAL LOCALIZATION WIRES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. GLOBAL OTHER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 17. GLOBAL ULTRASOUND GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 18. GLOBAL MAMMPGRAPHY GUIDED STEROTACTIC BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 19. GLOBAL CT-GUIDED BIOPSY MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 20. GLOBAL OTHER MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 21. GLOBAL BREAST BIOPSY IN HOSPITALS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 22. GLOBAL BREAST BIOPSY IN DIAGNOSTIC CENTRE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 23. GLOBAL BREAST BIOPSY IN RESAERCH INSTITUTE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 24. US BREAST BIOPSY MARKET SIZE, 2020-2027($ MILLION)
  • 25. CANADA BREAST BIOPSY MARKET SIZE, 2020-2027($ MILLION)
  • 26. UK BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. FRANCE BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. GERMANY BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. ITALY BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. SPAIN BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. REST OF EUROPE BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. INDIA BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. CHINA BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. JAPAN BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. SOUTH KOREA BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 36. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD BREAST BIOPSY MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2018373

Global Breast Biopsy Market Size, Share & Trends Analysis Report by Type (Fine Needle Biopsy, Core Needle Biopsy, Surgical Biopsy, and Others (Lymph Node and Vacuum-Assisted Biopsy)), By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kit, and Other), By Guided Technology (MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography Guided Stereotactic Biopsy, CT-Guided Biopsy and Other), By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period 2021-2027

The global breast biopsy market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2021-2027). A breast biopsy is a procedure in which tissues are removed from the affected or suspicious area. The removed cells are then examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is the only diagnostic procedure that can determine if the suspicious area is cancerous. Biopsy samples are sent to a laboratory for analysis where experts determine whether the cells are cancerous. The key factors contributing to the growth of the global breast biopsy market include the high prevalence of breast cancer, increasing breast cancer screening programs, rising adoption of minimally invasive breast biopsies, and high expenditure on breast cancer research.

Further, in Canada, as per the Canadian Cancer Society, in 2020 around 27,400 women were diagnosed with breast cancer, which was 25% new cancer cases that represent around 75 new breast cancer cases were diagnosed every day. In the US, one in eight women develops invasive breast cancer in its lifetime. Thus, the increasing number of cases has forced the government to raise awareness for the early detection of breast cancer globally. Moreover, the high cost of the procedure, risk, and harmful effects of breast biopsy are restraining the market. The introduction of new technologies such as vacuum-assisted biopsy, promising clinical trials, and raising awareness among women are some opportunities for the market.

Segmental Outlook

The global breast biopsy market is segmented based on type, product, guided technology, and end-user. Based on the type, the market is segmented into fine needle biopsy, core needle biopsy, surgical biopsy, and others. Further, others type is bifurcated into the lymph node and vacuum-assisted biopsy. The fine needle biopsy has a significant market share during the forecast period due to the rise in the demand for minimally invasive procedures, and the vacuum-assisted biopsy has significant growth during the forecast period owing to the less-invasive nature of this technique which makes a small incision through which needle is inserted. Based on the product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kit, and other. Besides, based on the guided technology, the market is segmented into MRI-guided biopsy, ultrasound-guided biopsy, mammography-guided biopsy, CT-guided biopsy, and others. Apart from it, based on the end-user, the market is segmented into hospitals, diagnostic centers, and research institutes.

Global Breast Biopsy Market Share by Product, 2020 (%)

Global Breast Biopsy Market Share by Product

Biopsy Needles holds a significant share in the Market

The biopsy needles held the major share in 2020 and are also anticipated to grow during the forecast period. The factors such as the rising adoption of image-guided procedures in emerging and developed economies, and the introduction of technologically advanced biopsy needles are driving the market growth during the forecast period. For instance, a pincer needle on the outermost edge, an outer cutting needle, and a sharp stylet on the inner side makes up the tri-axial needle. The needle design allows healthcare professionals to cut through tissue without compressing it. With the specific design of the needle, it is visible under ultrasound and CT, which are widely used for biopsy guidance.

Regional Outlooks

The global breast biopsy market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds a dominant position in the global breast biopsy market, followed by Europe. The growth is mainly due to the prevalence of breast cancer, rising adoption of minimally invasive breast biopsies significantly contributing towards the market growth in the region. For instance, as per the American Cancer Society, in 2021, it an estimated that around 281,550 new cases of invasive breast cancer are expected to be diagnosed in women in the US. Apart from it, around 49,290 new cases of non-invasive breast cancer in the US.

Global Breast Biopsy Market Growth, by Region 2021-2027

Global Breast Biopsy Market Growth, by Region

Asia-Pacific is projected to have a considerable share in the global breast biopsy market

Asia-Pacific is anticipated to hold a considerable market share in the global breast biopsy market. This is due to increasing breast cancer screening programs. The infrastructure of healthcare in emerging economies such as China, India, and South Korea is evolving at a rapid pace, leading to major investment in advanced systems by hospitals and breast centers is driving the growth of the Asia-Pacific breast biopsy market. Apart from it, the rising prevalence of breast cancer, the rising number of awareness programs for early detection of breast cancer, and the government spending on breast cancer research are the factors that are propelling the market growth in the region. For instance, as per the Organization for Economic Corporation and Development, in 2018, around 839,000 women were diagnosed with breast cancer and more than 286,000 mortalities occurred in the region.

Market Players Outlook

The key players of the breast biopsy market include Becton, Dickson and Co., Danaher Corp., Hologic, Inc., QIAGEN GmbH, F. Hoffman-La Roche Ltd., Argon Medical Devices, Inc., Cigna International, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, geographical expansion, collaborations, and new product launches, to stay competitive in the market. For instance, in May 2019, Argon Medical Devices, Inc., a manufacturer of specialty medical devices announced that it has acquired Mana-Tech Ltd., a distributor for the UK and Ireland. This acquisition was done to expand the commercial reach of argon's products.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global breast biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Opportunity Outlook
  • COVID-19 Impact Analysis
  • Recovery Scenarios
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Breast Biopsy Market by Type
    • 5.1.1. Fine Needle Biopsy
    • 5.1.2. Core Needle Biopsy
    • 5.1.3. Surgical Biopsy
    • 5.1.4. Others (Lymph Node and Vacuum Assisted Biopsy)
  • 5.2. Global Breast Biopsy Market by Product
    • 5.2.1. Biopsy Needles
    • 5.2.2. Guidance Systems
    • 5.2.3. Biopsy Tables
    • 5.2.4. Localization Wires
    • 5.2.5. Assay Kit
    • 5.2.6. Other
  • 5.3. Global Breast Biopsy Market by Guided Technology
    • 5.3.1. MRI-Guided Biopsy
    • 5.3.2. Ultrasound Guided Biopsy
    • 5.3.3. Mammography Guided Stereotactic Biopsy
    • 5.3.4. CT-Guided Biopsy
    • 5.3.5. Other
  • 5.4. Global Breast Biopsy Market by End-User
    • 5.4.1. Hospitals
    • 5.4.2. Diagnostic Centre
    • 5.4.3. Research Institute

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Argon Medical Devices, Inc.
  • 7.2. Becton, Dickinson and Co.
  • 7.3. Benetec Medical Systems
  • 7.4. Merit Medical Systems
  • 7.5. Cigna International Corp.
  • 7.6. Cook Group Inc.
  • 7.7. Danaher Corp.
  • 7.8. F. Hoffmann-La Roche Ltd.
  • 7.9. Hologic, Inc.
  • 7.10. IMS GIOTTO S.P.A.
  • 7.11. Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.)
  • 7.12. Medtronic plc
  • 7.13. NORAS MRI Products GmbH
  • 7.14. Oncocyte Corp.
  • 7.15. Planmeca Group
  • 7.16. QIAGEN GmbH
  • 7.17. Scion Medical Technologies, LLC.
  • 7.18. Trivitron Healthcare
  • 7.19. United Medical Systems Inc.
  • 7.20. VigeoSRL